STUDY OF DRUG INTERACTION POTENCY ON DIABETES MELLITUS PATIENT’S PRESCRIPTION IN OUTPATIENT GUNUNG JATI HOSPITAL CIREBON CITY
DOI:
https://doi.org/10.36465/jop.v1i2.331Abstract
Diabetes Mellitus (DM) is a group of metabolic diseases with characteristics of hyperglycemia that occur due to abnormalities in insulin secretion, insulin performance or both. Drug interactions are one of the drug-related problems that can affect patient therapy. The possibility of drug interactions increasing 2.5 times for each drug added to the patient's prescription, and in patients with diabetes mellitus is more susceptible to side effects from drug interactions. This study was conducted to find out what the number of potential events of drug interactions, how the severity of drug interactions, and how the type and amount of diabetes mellitus drugs interacted at the Outpatient Gunung Jati Hospital in Cirebon City. This research was conducted with observational design with descriptive analysis method by taking retrospective DM patient prescription data in January 2018. The results showed that from 100 prescriptions stated as a sample, 84 prescriptions (84%) experienced potential drug interactions, and 84 prescriptions there were 425 occurrences of drug interactions, potential drug interactions based on the severity, the number of incidence drug interactions of strict monitor/ significant / moderate were 291 (68.14%), minor were 120 (28.10%), serious were 15 (3.51%) and contra indication were 0 (0%). The results of the study of antidiabetic mellitus drugs that caused the most potential drug interactions, namely metformin, were 115 events.
Keywords: Diabetes Mellitus (DM), Drug Interaction Potential, Gunung Jati Hospital Cirebon City.
References
Anonim, 2013. International Diabetes Federation (IDF). IDF Diabetes Atlas Sixth Edition, International Diabetes Federation (IDF)
American Diabetes Association, Standards of medical care in diabetes2015, Diabetes Care. 2015, 37 (Suppl 1),S14-80.
Anonim.2008.Profil Kesehatan Indonesia 2008. Jakarta :Depkes RI 2008
Anonim.2013.Profil Kesehatan Indonesia 2013. Jakarta :Depkes RI 2013
Anonim. 2015. Laporan Kinerja Instansi Pemerintah RSUD Gunung Jati KotaCirebon Tahun 2015, Cirebon
Ansari, JA. 2010. Drug Interaction and Pharmacist. New Delhi: Journal of Young Pharmacist Vol. 2 No. 3
Arulselvi, A et al, Ida et al. 2013. Asian Journal of Phytomedicine and Clinical Research. 1(1), 2013, 20-26.
Ayungtyas, Maria FeaYessy. 2010. Evaluasi Drug Therapy Problems Obat Hipoglikemia Kombinasi Pada Pasien Geriatri Diabetes Mellitus Tipe 2 di Instalasi Rawat Jalan RSUP Dr. Sardjito Yogyakarta Periode Januari-Juni 2009 (Skripsi). Yogyakarta: Universitas Sanata Dharma.
Bushra Rabia., Nousheen Aslam, Arshad Yar Khan. 2011. Food-Drug Interactions. Oman Medical Journal (2011) Vol. 26, No. 2: 77-83
Dewi, Christina A. K et al. 2014. Drug Therapy Problems pada Pasien yang Menerima Resep Polifarmasi. Jurnal Farmasi Komunitas Vol.1, No.1, (2014) (P): 17-22
Dina Tri Amalia, dkk. 2014 . Rational Drug Prescription Writing. JUKE, Volume 4, Nomor 7, Maret Tahun 2014
Dipiro etal.2009. Pharmacotherapy Handbook Seventh Edition. McGraw Hill Medical
Eva S. Dasopang, Urip Harahap, Dharma Lindarto,2015.Polifarmasi dan Interaksi Obat Pasien Usia Lanjut Rawat Jalan dengan Penyakit Metabolik.Jurnal Farmasi Klinik Indonesia, Desember 2015 Tersedia online pada: Jurnal Farmasi Klinik Vol. 4 No. 4, hlm 235–241 ISSN: 2252–6218
Fajri Zakiyyatu Sa’adah, Fetri Lestari, Umi Yuniarni, 2016.Kajian Probabilitas Interaksi Obat Antidiabetes Golongan Sulfonilurea di Satu Rumah Sakit Umum Swasta Kota Bandung. Volume 2, No.2, Tahun 2016.
Gitawati, Retno. 2008. Interaksi Obat dan Beberapa Implikasinya. Media Litbang Kesehatan Volume XVIII Nomor 4. P: (175-184)
Kasif, S et al. 2012. Drug Interaction: A Brief of Preventive Approaches. International Journal of Universal Pharmacy and Life Sciences 2(3): May-June 2012.
Kepmenkes. Nomor 35/MENKES/SK/IX/2014 tentang Standar Pelayanan Kefarmasian di Apotek. Menteri Kesehatan Republik Indonesia.
Kepmenkes. Nomor 09/MENKES/SK/IX/2017 tentang Apotek. Menteri Kesehatan Republik Indonesia.
Kepmenkes. Nomor 72/MENKES/SK/IX/2016 tentang Standar Pelayanan Kefarmasian di Rumah Sakit. Menteri Kesehatan Republik Indonesia.
Nurlaela, Ida et al. 2015. GALENIKA Journal of Pharmacy Vol. 1 (1) : 35 - 41 ISSN : 2442-8744 March 2015
Penzak, Scott. 2010. Drug Interactions. Clinical Pharmacokinetics Research Laboratory Clinical Center Pharmacy Department National Institutes of Health.
PERKENI, 2015,Pengelolaan Dan Pencegahan Diabetes Mellitus Tipe 2 Di Indonesia, PERKENI.
RISKESDAS, 2013.Riset Kesehatan Dasar prevalensi diabetes mellitus .2013
Santi Purna Sari, Mahdi Jufri, dan Dini Permana Sari,2008.Analisis Interaksi Obat Antidiabetik Oral Pada Pasien Rawat Jalan Di Rumah Sakit X Depok.Jurnal Farmasi Indonesia Vol. 4 No. 1 Januari 2008: 8 – 14
Stockley, Ivan., Sean Sweetman, Karen Baxter. 2008. Stockley’s Drug Interactions 8th Edition. London: Pharmaceutical Press
Utami, Mega Gustiani,. 2013. Analisis Potensi Interaksi Obat Antidiabetik Oral Pada Pasien Di Instalasi Rawat Jalan Askes Rumah Sakit Dokter Soedarso Pontianak Periode Januari-Maret 2013. Pontianak: Universitas Tanjung Pura.
Anonim, 2013 , Diabetes Mellitus: World Health Organization. Available: http://www.who.int/mediacentre/factsheets/fs312/en/
